chr2-151687639-T-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BS1BS2_Supporting

The NM_001164507.2(NEB):​c.2510A>G​(p.Lys837Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000593 in 1,612,828 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 2 hom. )

Consequence

NEB
NM_001164507.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:8

Conservation

PhyloP100: -0.0430

Publications

4 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052112937).
BP6
Variant 2-151687639-T-C is Benign according to our data. Variant chr2-151687639-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 287622.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00117 (178/152312) while in subpopulation AFR AF = 0.00265 (110/41570). AF 95% confidence interval is 0.00224. There are 0 homozygotes in GnomAd4. There are 91 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.2510A>G p.Lys837Arg missense_variant Exon 26 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.2510A>G p.Lys837Arg missense_variant Exon 26 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.2510A>G p.Lys837Arg missense_variant Exon 26 of 182 5 NM_001164508.2 ENSP00000380505.3
NEBENST00000427231.7 linkc.2510A>G p.Lys837Arg missense_variant Exon 26 of 182 5 NM_001164507.2 ENSP00000416578.2
NEBENST00000409198.5 linkc.2510A>G p.Lys837Arg missense_variant Exon 26 of 150 5 ENSP00000386259.1

Frequencies

GnomAD3 genomes
AF:
0.00117
AC:
178
AN:
152194
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000930
AC:
228
AN:
245282
AF XY:
0.000902
show subpopulations
Gnomad AFR exome
AF:
0.00269
Gnomad AMR exome
AF:
0.00141
Gnomad ASJ exome
AF:
0.00740
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000470
Gnomad OTH exome
AF:
0.00184
GnomAD4 exome
AF:
0.000533
AC:
778
AN:
1460516
Hom.:
2
Cov.:
32
AF XY:
0.000523
AC XY:
380
AN XY:
726452
show subpopulations
African (AFR)
AF:
0.00293
AC:
98
AN:
33466
American (AMR)
AF:
0.00128
AC:
57
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
188
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86180
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53336
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5766
European-Non Finnish (NFE)
AF:
0.000311
AC:
346
AN:
1111170
Other (OTH)
AF:
0.00106
AC:
64
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00117
AC:
178
AN:
152312
Hom.:
0
Cov.:
32
AF XY:
0.00122
AC XY:
91
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00265
AC:
110
AN:
41570
American (AMR)
AF:
0.00144
AC:
22
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68024
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000913
Hom.:
0
Bravo
AF:
0.00140
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00231
AC:
9
ESP6500EA
AF:
0.000965
AC:
8
ExAC
AF:
0.000894
AC:
108
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: BP4 -

Jun 07, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 17, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25203624) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nemaline myopathy 2 Uncertain:1Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Uncertain:1
Jan 18, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: NEB c.2510A>G (p.Lys837Arg) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00093 in 245282 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in NEB causing Nemaline Myopathy 2 (0.00093 vs 0.0035), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.2510A>G in individuals affected with Nemaline Myopathy 2 and no experimental evidence demonstrating its impact on protein function have been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluations, and classified as VUS (n=2) and Likely Benign (n=4). Based on the evidence outlined above, the variant was classified as uncertain significance. -

NEB-related disorder Benign:1
Jun 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
4.2
DANN
Benign
0.96
DEOGEN2
Benign
0.022
.;.;T;.;T;.;.
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.74
T;T;T;T;T;.;.
M_CAP
Benign
0.0032
T
MetaRNN
Benign
0.0052
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.60
N;N;.;N;N;N;N
PhyloP100
-0.043
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.52
N;N;.;N;N;.;.
REVEL
Benign
0.097
Sift
Benign
0.25
T;T;.;T;T;.;.
Sift4G
Benign
0.45
T;T;T;T;T;T;T
Polyphen
0.0010
.;.;.;.;B;.;.
Vest4
0.17
MVP
0.33
MPC
0.046
ClinPred
0.0058
T
GERP RS
-4.9
Varity_R
0.049
gMVP
0.093
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189623595; hg19: chr2-152544153; COSMIC: COSV99428110; COSMIC: COSV99428110; API